Dragon’s Blood as a promising strategy against cerebral ischemia-induced memory processing impairment
- 1hijiazhuang Medical College, Shijiazhuang, Hebei, China
Abstract
Cerebral ischemia frequently triggers persistent learning and memory dysfunction, which is closely associated with structural and functional impairments of memory-related brain regions including the hippocampus, amygdala and cerebral cortex. Disrupted oxidative homeostasis, excessive neuroinflammation, synaptic degeneration and imbalanced neurotransmitter signaling jointly constitute cascaded pathological processes that destroy the integrity of hippocampus-amygdala-prefrontal cortex circuit. Dragon’s Blood, a traditional herbal medicine with multiple bioactive constituents, exhibits prominent antioxidant, anti-inflammatory and neuroprotective properties. Accumulating evidence indicates that Dragon’s Blood and its major active components (loureirins and pterostilbene) can alleviate ischemic neuronal injury, stabilize synaptic structure, restore the balance of multiple neurotransmitter systems, and reconstruct damaged memory circuits. This review systematically summarizes the multi-target mechanisms by which Dragon’s Blood ameliorates cerebral ischemia-induced memory impairment, focusing on its regulatory effects on oxidative stress, microglial polarization, synaptic plasticity and interregional neural circuits. We further discuss existing limitations of current research and prospective directions for subsequent preclinical and translational investigations. This work aims to provide theoretical references for developing natural compound-based interventions against post-stroke cognitive disorders.
Related
- Cognitive impairment after cerebral ischemia-reperfusion injury: a neuroecosystem perspective.
- Persistent Alzheimer-related molecular dysregulation after cerebral ischemia: a hierarchical-circular hypothesis of impaired allostatic recovery
- ACSS2 phosphorylation at Ser659 attenuates neuronal apoptosis induced by cerebral ischemia-reperfusion by initiating autophagy
- Atractylenolide I ameliorates microglia-mediated cerebral ischemia/reperfusion injury by suppressing the TLR4/NF-κB/NLRP3 inflammasome axis
- Chrysanthemum morifolium extract prevents oxidative stress and ferroptosis in cerebral ischemia-reperfusion injury by modulating the miR-144/Nrf2 pathway
BibTeX
@article{chen2026dragons,
title = {{Dragon’s Blood as a promising strategy against cerebral ischemia-induced memory processing impairment}},
author = {Pinqiu Chen and Jingjing Zhang and Xiangli Yao},
journal = {Frontiers in Cellular Neuroscience},
year = {2026},
month = oct,
doi = {10.3389/fncel.2026.1960961},
url = {https://doi.org/10.3389/fncel.2026.1960961},
note = {CC BY},
}
RIS
TY - JOUR
TI - Dragon’s Blood as a promising strategy against cerebral ischemia-induced memory processing impairment
AU - Pinqiu Chen
AU - Jingjing Zhang
AU - Xiangli Yao
PY - 2026
DA - 2026/10/27
JO - Frontiers in Cellular Neuroscience
DO - 10.3389/fncel.2026.1960961
UR - https://doi.org/10.3389/fncel.2026.1960961
AB - Cerebral ischemia frequently triggers persistent learning and memory dysfunction, which is closely associated with structural and functional impairments of memory-related brain regions including the hippocampus, amygdala and cerebral cortex. Disrupted oxidative homeostasis, excessive neuroinflammation, synaptic degeneration and imbalanced neurotransmitter signaling jointly constitute cascaded pathological processes that destroy the integrity of hippocampus-amygdala-prefrontal cortex circuit. Dragon’s Blood, a traditional herbal medicine with multiple bioactive constituents, exhibits prominent antioxidant, anti-inflammatory and neuroprotective properties. Accumulating evidence indicates that Dragon’s Blood and its major active components (loureirins and pterostilbene) can alleviate ischemic neuronal injury, stabilize synaptic structure, restore the balance of multiple neurotransmitter systems, and reconstruct damaged memory circuits. This review systematically summarizes the multi-target mechanisms by which Dragon’s Blood ameliorates cerebral ischemia-induced memory impairment, focusing on its regulatory effects on oxidative stress, microglial polarization, synaptic plasticity and interregional neural circuits. We further discuss existing limitations of current research and prospective directions for subsequent preclinical and translational investigations. This work aims to provide theoretical references for developing natural compound-based interventions against post-stroke cognitive disorders.
SN - 1662-5102
ER -